157 related articles for article (PubMed ID: 38773406)
1. Epithelial-to-mesenchymal transition and NF-kB pathways are promoted by a mutant form of DDB2, unable to bind PCNA, in UV-damaged human cells.
Perucca P; Bassi E; Vetro M; Tricarico A; Prosperi E; Stivala LA; Cazzalini O
BMC Cancer; 2024 May; 24(1):616. PubMed ID: 38773406
[TBL] [Abstract][Full Text] [Related]
2. Exploring new potential role of DDB2 by host cell reactivation assay in human tumorigenic cells.
Bassi E; Perucca P; Guardamagna I; Prosperi E; Stivala LA; Cazzalini O
BMC Cancer; 2019 Oct; 19(1):1013. PubMed ID: 31664956
[TBL] [Abstract][Full Text] [Related]
3. A damaged DNA binding protein 2 mutation disrupting interaction with proliferating-cell nuclear antigen affects DNA repair and confers proliferation advantage.
Perucca P; Mocchi R; Guardamagna I; Bassi E; Sommatis S; Nardo T; Prosperi E; Stivala LA; Cazzalini O
Biochim Biophys Acta Mol Cell Res; 2018 Jun; 1865(6):898-907. PubMed ID: 29604309
[TBL] [Abstract][Full Text] [Related]
4. A DDB2 mutant protein unable to interact with PCNA promotes cell cycle progression of human transformed embryonic kidney cells.
Perucca P; Sommatis S; Mocchi R; Prosperi E; Stivala LA; Cazzalini O
Cell Cycle; 2015; 14(24):3920-8. PubMed ID: 26697842
[TBL] [Abstract][Full Text] [Related]
5. DDB2 association with PCNA is required for its degradation after UV-induced DNA damage.
Cazzalini O; Perucca P; Mocchi R; Sommatis S; Prosperi E; Stivala LA
Cell Cycle; 2014; 13(2):240-8. PubMed ID: 24200966
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway.
Peng B; Ortega J; Gu L; Chang Z; Li GM
J Biol Chem; 2019 Apr; 294(17):7037-7045. PubMed ID: 30858175
[TBL] [Abstract][Full Text] [Related]
7. DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma.
Bommi PV; Ravindran S; Raychaudhuri P; Bagchi S
Oncotarget; 2018 Oct; 9(78):34708-34718. PubMed ID: 30410671
[TBL] [Abstract][Full Text] [Related]
8. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
9. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
10. Damaged DNA-binding protein 2 (DDB2) protects against UV irradiation in human cells and Drosophila.
Sun NK; Sun CL; Lin CH; Pai LM; Chao CC
J Biomed Sci; 2010 Apr; 17(1):27. PubMed ID: 20398405
[TBL] [Abstract][Full Text] [Related]
11. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
12. DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells.
Barbieux C; Bacharouche J; Soussen C; Hupont S; Razafitianamaharavo A; Klotz R; Pannequin R; Brie D; Bécuwe P; Francius G; Grandemange S
Nanoscale; 2016 Mar; 8(9):5268-79. PubMed ID: 26879405
[TBL] [Abstract][Full Text] [Related]
13. The cullin 4B-based UV-damaged DNA-binding protein ligase binds to UV-damaged chromatin and ubiquitinates histone H2A.
Guerrero-Santoro J; Kapetanaki MG; Hsieh CL; Gorbachinsky I; Levine AS; Rapić-Otrin V
Cancer Res; 2008 Jul; 68(13):5014-22. PubMed ID: 18593899
[TBL] [Abstract][Full Text] [Related]
14. DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.
Roy N; Bommi PV; Bhat UG; Bhattacharjee S; Elangovan I; Li J; Patra KC; Kopanja D; Blunier A; Benya R; Bagchi S; Raychaudhuri P
Cancer Res; 2013 Jun; 73(12):3771-82. PubMed ID: 23610444
[TBL] [Abstract][Full Text] [Related]
15. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
16. DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy.
Dardare J; Witz A; Betz M; Francois A; Meras M; Lamy L; Lambert A; Grandemange S; Husson M; Rouyer M; Demange J; Merlin JL; Harlé A; Gilson P
Front Oncol; 2022; 12():1052163. PubMed ID: 36568213
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
18. UV-induced DNA incision and proliferating cell nuclear antigen recruitment to repair sites occur independently of p53-replication protein A interaction in p53 wild type and mutant ovarian carcinoma cells.
Riva F; Zuco V; Vink AA; Supino R; Prosperi E
Carcinogenesis; 2001 Dec; 22(12):1971-8. PubMed ID: 11751427
[TBL] [Abstract][Full Text] [Related]
19. The miRNA125a-5p and miRNA125b-1-5p cluster induces cell invasion by down-regulating DDB2-reduced epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Zhu F; Wei J; He D; He J; Liu L; Hou H; Shi H; Jin S; Li J; Shi X; Liu P; Huang M
J Gastrointest Oncol; 2022 Dec; 13(6):3112-3122. PubMed ID: 36636074
[TBL] [Abstract][Full Text] [Related]
20. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
